PhaseBio Pharmaceuticals, Inc. (PHAS) Earnings
|
Expand Research on PHAS
| Next EPS Date | N/A | EPS Growth Rate | N/A |
|---|---|---|---|
| Average EPS % Beat Rate | -23.4% | Revenue Growth Rate | N/A |
| Average % Move 1-Wk after EPS | -1.5% | Normal Earnings Time | N/A |
| Date | Qtr | EPS | Cons. | Surprise | Revs | Cons. | Gd. | 1-Week % | 1-Day % | Details | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 11/17/22 | Q322 | N/A | -$0.33 | N/A | N/A | $1.25M | N/A | N/A | N/A | ||
| 8/12/22 | Q222 | -$0.60 | -$0.31 | -$0.29 | $10.34M | $833.33K | N/A |  | | Details |
